Hims & Hers: Not Selling Yet

2026-03-09 17:51:27 ET

Hims & Hers ( HIMS ) shares surged as much as 55% in pre-market trading on Monday morning after news that the company is creeping back into bed with Novo Nordisk ( NVO ). The excitement has calmed slightly, with the stock now up almost 40% at ~$22 per share. We called sell on Hims on the thesis that the stock is a $20s stock without GLP-1 and subsequently upgraded on greenshoots from personalized plans and active discussions with Novo. The stock fell another 46% after that. Now, we’re back to reassess Hims stock in the presence of both GLP-1 and Novo and maintaining our buy-rating. ...

Read the full article on Seeking Alpha

For further details see: